232 related articles for article (PubMed ID: 20175752)
1. ZEB1 and CtBP form a repressive complex at a distal promoter element of the BCL6 locus.
Papadopoulou V; Postigo A; Sánchez-Tilló E; Porter AC; Wagner SD
Biochem J; 2010 Apr; 427(3):541-50. PubMed ID: 20175752
[TBL] [Abstract][Full Text] [Related]
2. BCL6 induces EMT by promoting the ZEB1-mediated transcription repression of E-cadherin in breast cancer cells.
Yu JM; Sun W; Hua F; Xie J; Lin H; Zhou DD; Hu ZW
Cancer Lett; 2015 Sep; 365(2):190-200. PubMed ID: 26049022
[TBL] [Abstract][Full Text] [Related]
3. MCRIP1, an ERK substrate, mediates ERK-induced gene silencing during epithelial-mesenchymal transition by regulating the co-repressor CtBP.
Ichikawa K; Kubota Y; Nakamura T; Weng JS; Tomida T; Saito H; Takekawa M
Mol Cell; 2015 Apr; 58(1):35-46. PubMed ID: 25728771
[TBL] [Abstract][Full Text] [Related]
4. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.
Phan RT; Dalla-Favera R
Nature; 2004 Dec; 432(7017):635-9. PubMed ID: 15577913
[TBL] [Abstract][Full Text] [Related]
5. ZEB1 imposes a temporary stage-dependent inhibition of muscle gene expression and differentiation via CtBP-mediated transcriptional repression.
Siles L; Sánchez-Tilló E; Lim JW; Darling DS; Kroll KL; Postigo A
Mol Cell Biol; 2013 Apr; 33(7):1368-82. PubMed ID: 23339872
[TBL] [Abstract][Full Text] [Related]
6. The gene for interleukin-21 receptor is the partner of BCL6 in t(3;16)(q27;p11), which is recurrently observed in diffuse large B-cell lymphoma.
Ueda C; Akasaka T; Kurata M; Maesako Y; Nishikori M; Ichinohasama R; Imada K; Uchiyama T; Ohno H
Oncogene; 2002 Jan; 21(3):368-76. PubMed ID: 11821949
[TBL] [Abstract][Full Text] [Related]
7. The expression levels of the transcriptional regulators p300 and CtBP modulate the correlations between SNAIL, ZEB1, E-cadherin and vitamin D receptor in human colon carcinomas.
Peña C; García JM; García V; Silva J; Domínguez G; Rodríguez R; Maximiano C; García de Herreros A; Muñoz A; Bonilla F
Int J Cancer; 2006 Nov; 119(9):2098-104. PubMed ID: 16804902
[TBL] [Abstract][Full Text] [Related]
8. The transcription repressor, ZEB1, cooperates with CtBP2 and HDAC1 to suppress IL-2 gene activation in T cells.
Wang J; Lee S; Teh CE; Bunting K; Ma L; Shannon MF
Int Immunol; 2009 Mar; 21(3):227-35. PubMed ID: 19181930
[TBL] [Abstract][Full Text] [Related]
9. The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis.
Baron BW; Anastasi J; Thirman MJ; Furukawa Y; Fears S; Kim DC; Simone F; Birkenbach M; Montag A; Sadhu A; Zeleznik-Le N; McKeithan TW
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2860-5. PubMed ID: 11854457
[TBL] [Abstract][Full Text] [Related]
10. CtBP is an essential corepressor for BCL6 autoregulation.
Mendez LM; Polo JM; Yu JJ; Krupski M; Ding BB; Melnick A; Ye BH
Mol Cell Biol; 2008 Apr; 28(7):2175-86. PubMed ID: 18212045
[TBL] [Abstract][Full Text] [Related]
11. BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms.
Parekh S; Polo JM; Shaknovich R; Juszczynski P; Lev P; Ranuncolo SM; Yin Y; Klein U; Cattoretti G; Dalla Favera R; Shipp MA; Melnick A
Blood; 2007 Sep; 110(6):2067-74. PubMed ID: 17545502
[TBL] [Abstract][Full Text] [Related]
12. Regulation of muscle atrophy-related genes by the opposing transcriptional activities of ZEB1/CtBP and FOXO3.
Ninfali C; Siles L; Darling DS; Postigo A
Nucleic Acids Res; 2018 Nov; 46(20):10697-10708. PubMed ID: 30304480
[TBL] [Abstract][Full Text] [Related]
13. The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain.
Deweindt C; Albagli O; Bernardin F; Dhordain P; Quief S; Lantoine D; Kerckaert JP; Leprince D
Cell Growth Differ; 1995 Dec; 6(12):1495-503. PubMed ID: 9019154
[TBL] [Abstract][Full Text] [Related]
14. Novel CTCF binding at a site in exon1A of BCL6 is associated with active histone marks and a transcriptionally active locus.
Batlle-López A; Cortiguera MG; Rosa-Garrido M; Blanco R; del Cerro E; Torrano V; Wagner SD; Delgado MD
Oncogene; 2015 Jan; 34(2):246-56. PubMed ID: 24362533
[TBL] [Abstract][Full Text] [Related]
15. Targeted somatic mutation of the BCL6 proto-oncogene and its impact on lymphomagenesis.
Jardin F; Sahota SS
Hematology; 2005 Apr; 10(2):115-29. PubMed ID: 16019457
[TBL] [Abstract][Full Text] [Related]
16. FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5/BCL6-dependent mechanism.
Fernández de Mattos S; Essafi A; Soeiro I; Pietersen AM; Birkenkamp KU; Edwards CS; Martino A; Nelson BH; Francis JM; Jones MC; Brosens JJ; Coffer PJ; Lam EW
Mol Cell Biol; 2004 Nov; 24(22):10058-71. PubMed ID: 15509806
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of ZEB1 by miR-200 characterizes Helicobacter pylori-positive gastric diffuse large B-cell lymphoma with a less aggressive behavior.
Huang WT; Kuo SH; Cheng AL; Lin CW
Mod Pathol; 2014 Aug; 27(8):1116-25. PubMed ID: 24390222
[TBL] [Abstract][Full Text] [Related]
18. Coordinative modulation of human zinc transporter 2 gene expression through active and suppressive regulators.
Lu YJ; Liu YC; Lin MC; Chen YT; Lin LY
J Nutr Biochem; 2015 Apr; 26(4):351-9. PubMed ID: 25618524
[TBL] [Abstract][Full Text] [Related]
19. Regulation of corepressor function by nuclear NADH.
Zhang Q; Piston DW; Goodman RH
Science; 2002 Mar; 295(5561):1895-7. PubMed ID: 11847309
[TBL] [Abstract][Full Text] [Related]
20. Roles of USF, Ikaros and Sp proteins in the transcriptional regulation of the human reduced folate carrier B promoter.
Liu M; Whetstine JR; Payton SG; Ge Y; Flatley RM; Matherly LH
Biochem J; 2004 Oct; 383(Pt 2):249-57. PubMed ID: 15214842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
